Scynexis (SCYX) Shares Outstanding (Diluted) (2013 - 2026)
Scynexis (SCYX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 833.33 Mn |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | 11.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.82 Mn |
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 6.24 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 6.06 Mn |
| Sep 30, 2024 | 6.08 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 6.24 Mn |
| Mar 31, 2023 | 5.97 Mn |
| Dec 31, 2022 | 5.33 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 3.47 Mn |